Experimental immunotherapy considerably delays onset of kind 1 diabetes
If teplizumab is approved for use, it could be the first drug to delay the onset or completely prevent type 1 diabetes in risk...
Eli Lilly’s diabetes drug diminished weight and blood sugar in trial
Unlock this article by subscribing to STAT + and enjoy your first 30 days for free!
GETTING STARTED
What is it?
STAT + is STAT's premium subscription...
Replace on the design of a Section III Precision Medication trial with the Diabetes...
STOCKHOLM, March 4, 2021 / PRNewswire / -
The upcoming phase III study with Diamyd® in emerging type 1 diabetes is based on the first...
International Diabetes Diagnostics Market to the touch US$ 35 Bn by 2025 at a...
Noida, Uttar Pradesh, India, March 04, 2021 (WiredRelease) Ocean Pvt Ltd– report:...
Over 25computer Pakistanis feared to be affected by diabetes – Newspaper
KARACHI: Health experts and medical professionals warned on Wednesday that more than a quarter of the population of Pakistan suffers from a lifestyle disease,...
Diabetes examine furthers work on ‘synthetic pancreas’
The Medtronic MiniMed Advanced Hybrid Closed Loop System (AHCL).Another step towards an “artificial pancreas” to improve the health of people with type 1 diabetes...
Immunotherapy drug delays onset of Sort 1 diabetes in at-risk group
More than five years after receiving an experimental immunotherapy drug, half of a group of people at high risk of developing type...